Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Pegintron
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
PegIntron 100microgram inj vials
0802040A0BCABAB
|
Pegintron | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegintron 120microgram inj vials
0802040A0BCAEAE
|
Pegintron | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegintron 150microg inj vials
0802040A0BCADAD
|
Pegintron | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegintron 50microgram inj vials
0802040A0BCACAC
|
Pegintron | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegintron 80microgram inj vials
0802040A0BCAAAA
|
Pegintron | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.